Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Pidilizumab (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 05 Nov 2010 New trial record.